Top 2 pharma stocks to buy amid surge in deadly fungi
Deadly fungi including Candida auris have been spreading. Gilead and Merck are two pharma stocks worth owning amidst fungal ...
Antifungal Drugs Market Projected to Reach USD 19.16 Billion by 2030 Amid Rising Incidence of Fungal Infections - Global Research 2024
The "Anti Fungal Drugs - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.In a comprehensive analysis, experts forecast the ...
STAT6d
A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark
A drug used by cancer patients may make chemotherapies less effective in patients with obesity — but many doctors are in the ...
N.Y. doctors report first U.S. cases of sexually transmitted ringworm
Doctors in New York City are describing the first known U.S. cases of sexually transmitted ringworm, which can cause a nasty ...
Medical Xpress on MSN12d
Antibiotics and Antifungals May Slightly Affect Parkinson's Risk, Study Finds
In addition to the reduced risk associated with penicillin use, the study found people who took two or more courses of ...
dermatologyadvisor11h
First Cases of Sexually Transmitted Ringworm Reported in the United States
Doctors in New York City are chronicling the first known United States cases of sexually transmitted ringworm (Trichophyton mentagrophytes).
The Hoya3d
Seminar Explores How Pathogenic Fungi Evade Drugs, Implications for Human Health
Neeraj Chauhan, Ph.D., an associate professor in the Center for Discovery and Innovation at Hackensack Meridian Health, ...
Medscape11d
Emerging Fungal Infections Demand All-Out Approach
Trichophyton indotineae is changing the way we talk about dermatophyte infections,” said NYU dermatologist Avrom S. Caplan, ...
EurekAlert!1d
ObesityWeek® research on Nov. 3 demonstrates gaps in drug labeling for people with obesity
SAN ANTONIO, Tx - Cancer patients need a lot of drugs—immunotherapies, chemotherapies, and anti-infectives. But new research at ObesityWeek® on Nov. 3, 2024, shows clinicians may not have all the ...